

Add to Cart
150mg 5ml Stimulates Collagen Production PLLA Powder injection
dermal fillerss dermal filler
dermal fillerss injections are a natural way to restore lost facial
collagen. It contains poly-L-lactic acid, or PLLA, a substance that
belongs to the alpha-hydroxy acid group. Poly-L-lactic acid is a
synthetic polymer, and has been used for years in absorbable
surgical sutures or stitches.
dermal fillerss functions as a facial filler either for cosmetic
reasons or for medical purposes to restore and correct the signs of
facial loss in patients including those diagnosed with HIV.
Poly-L-lactic acid is a biocompatible and biodegradable polymer.
You can buy dermal fillerss in the form of dermal fillerss 150mg
strength vials, which must be reconstituted before use by adding
5ml of sterile water for the injection, forming a sterile
non-pyrogenic suspension.
How dermal fillerss Works:
The micro-particles of Poly-L-lactic acid in dermal fillerss is
mixed with sterile water and then injected. It is then deposited
under the skin, after which dermal fillerss breaks down and
stimulates collagen production. The drug works by raising the
volume of the depressed areas in the face gradually over a period
of time. After 2 or 3 treatments that are separated by intervals of
4 or 6 weeks, patients will notice a natural and youthful
difference in there skin.. The effects of dermal fillerss can last
for as long as 2 years.
dermal fillerss | dermal fillerss | ||
specification |
| ||
Grade |
| ||
packing |
| ||
Functions | Poly L Lactic Acid | ||
Color | white color | ||
shelf | 2 years | ||
trademark | dermal fillerss | ||
product name | dermal fillerss injection dermal fillerss butt filler dermal fillerss | ||
ingredient | plla |
There are a few precautions that need to be kept in mind when you
buy dermal fillerss. These are:
* There is a risk of inflammatory reactions on the injected site if
a patient undergoes any treatment that requires active dermal
response after administering dermal fillerss. Examples of such
treatment would include laser treatment and chemical peeling.
* The safety and efficacy of dermal fillerss has not been evaluated
if it is given in large amounts in various frequencies in
siteswhere signs of lipoatrophy are not present, or in sites where
other dermal fillers were injected.
* The safety and efficacy of Scuptra has not been evaluated for use
in the lips. Do not inject dermal fillerss into the red area,
i.e.the vermillion of the lip.
* dermal fillerss is to be injected into the subcutaneous layer or
the deep dermis. If it is injected superficially, it may result in
side effects like papules and nodules.
* Papules and nodules may be formed if the dermal fillerss is
injected in the peri-orbital area.
* dermal fillerss should not be mixed with other dermal fillers and
injected into the face.
* dermal fillerss should only be administered by a medically
trained professional to correct lipoatrophy in HIV patients after
the professional is fully familiar with the patient's history, the
product, and the entire package insert.